{
    "2021-09-28": [
        [
            {
                "time": "",
                "original_text": "群益证券给予泰格医药买进评级：订单充裕，将持续受益于医药行业研发景气",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "买进评级",
                        "订单充裕",
                        "医药行业",
                        "研发景气"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "解盘：资源股重新活跃，电力、煤炭、工业母机略涨",
                "features": {
                    "keywords": [
                        "资源股",
                        "电力",
                        "煤炭",
                        "工业母机"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "能源",
                        "工业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创业板指涨超1%，迈瑞医疗、东方财富、泰格医药、康龙化成等走强",
                "features": {
                    "keywords": [
                        "创业板指",
                        "迈瑞医疗",
                        "东方财富",
                        "泰格医药",
                        "康龙化成"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "派格生物：泰格医药“突击”注资 ，两大核心药品均不具备先发优势",
                "features": {
                    "keywords": [
                        "派格生物",
                        "泰格医药",
                        "注资",
                        "核心药品",
                        "先发优势"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}